Skuldtech has developed a biomolecular training kit, which provides a pedagogical and guided approach to molecular biology techniques including PCR, hybridization on membranes, bioinformatics...
In the respect of French Bachelor degree’s programs, Skuldtech provides the « Mini-Array Enseignement » kit, a pedagogical and guided approach to Molecular Biology techniques using PCR and membrane hybridization.
This product proposes to use the following techniques of molecular biology:
Nucleic acid extraction and purification,
Nucleic acid amplification by PCR,
Nucleic fragment analyses by electrophoresis,
Use of a detection technique by membrane hybridization,
Research and analysis of nucleic sequences in bioinformatics databases…
To obtain more information concerning our product, you can download its presentation (flyer).
The « Mini-Array Enseignement » kit has several advantages including stability during the shipment, the possibility to be stored several months, and it is currently used by several French high schools or universities.
To obtain more details or our references, please contact us by phone (+33 (0)467 419 748) or email:
info@skuldtech.com.
To order the « Mini-Array Enseignement” kit, please download the purchase order.
For the teachers, who have already bought the « Mini-Array Enseignement” kit, a training package can be downloaded here:
student training kit.
In this package, several documents are provided: an electronic version of the user manual, some supports to prepare the molecular biology practical’s lessons, but also some documents concerning the bioinformatics practical’s lessons: research of sequences in databases using BLAST tool, the FASTA conversion of sequences, the research of specific PCR primers (Primer3Plus), the alignment of sequences with ClustalW, the 3D visualization of a protein structure.
If you have any question or request or if you wish to receive a quotation, please contact our commercial department (Tel: +33 (0)467 419 748), Email: info@skuldtech.com).
Skuldtech is specialized in the discovery of
new Biomarkers and the development of Diagnostics
focused on personalized medicine applications.
This expertise enables the company to provide
genomic, pharmacogenomic and transcriptomic services,
as well as innovative diagnostics
associated with new
treatments, especially in
cancer, neurodegenerative and
infectious diseases.